Huxley Foundation, founded by Albert Hobohm, supports exceptional researchers in the field of psychedelic science, focusing on exploring consciousness and treating mental illness.

Helus Pharma™, the commercial operating name of Cybin Inc., is a clinical stage pharmaceutical company committed to helping minds heal by developing proprietary NSAs - novel serotonergic agonists: synthetic molecules designed to activate serotonin pathways that are believed to promote neuroplasticity. Helus Pharma’s proprietary NSAs are intended to address the large unmet need for people who suffer from depression, anxiety, and other mental health conditions. With class leading data, Helus Pharma aims to improve the treatment landscape through the introduction of NSAs that aim to provide durable improvements in mental health. Helus Pharma is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and HLP004, also a proprietary NSA in Phase 2 for generalized anxiety disorder. Additionally, Helus Pharma has an extensive research portfolio of investigational NSAs.

Improbability Foundation inspires, promotes, and supports projects that advance our understanding and accelerate the development of the human brain in the domains of science, education, sports, arts, and culture.

Norrsken Mind is a foundation focused on supporting research on psychedelic substances and their potential to treat mental health disorders through fundraising and grant opportunities. Our goal is to catalyse more research across Europe to improve the understanding of psychedelic-assisted treatments, as well as to inform and engage with mental health stakeholders through education and training efforts.

PsyLabs is a biotechnology company focused on the development of standardised, high-purity psychedelic compounds for clinical research and therapeutic applications.

Worldwide Clinical Trials (Worldwide) is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality. Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. Our deep therapeutic knowledge enables us to develop flexible plans and quickly solve problems for our customers.

As the first ever university-affiliated psychedelic training program, the CIIS Psychedelic Certificate is the gold standard for holistic and rigorous education in psychedelic-assisted therapies and research.

Evidence-based relationship therapy for couples, individuals, and modern partnerships, including traditional and ketamine-assisted care.

Lobelia labs founded in 2018 is a venture fund & fund advisory that aims to maximize potential across industries through investment, development and implementation of cutting edge technologies and fundraising.

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders.

PsyDAO is a decentralized organization dedicated to progressing psychedelic science & culture.

RiverStyx Foundation is a philanthropic organization that strives to work at this boundary place. Through grant-making, seeding non-profits, and engaged capacity building, Riverstyx attends to the places in society and our psychology which have been relegated to the shadows- out of fear, ignorance, and puritan influence- recognizing that which is repressed only festers and breeds pathology in its unnatural separation.

ACER Integration is a yearlong, guided online program designed to foster lasting connection to self, others, and the natural world, inspired by the principles of psychological theory and nature's wisdom.

Alaya Foundation explores and promotes innovative approaches to psychological well-being and personal growth, combining scientific rigor with a deep understanding of the human dimension.

The ALPS Foundation educates professionals and the public on evidence-based psychedelic research and therapy, emphasizing the profound potential of psychedelics to foster connection.

The Amsterdam Psychedelic Research Association (APRA) is an interdisciplinary academic association for university students and researchers in Amsterdam.

Blossom is dedicated to advancing knowledge in psychedelics through a suite of research and educational resources, including Blossom Analysis (a research database and commentary hub).

Center for Psykedelisk Dannelse (Cepda) is a Danish think tank promoting responsible, evidence-based psychedelic approaches through research, education, and community building.

Chacruna promotes reciprocity, protects sacred plants and traditions, and advances psychedelic justice by uplifting marginalized voices in psychedelic science and education.

Clearmind Medicine is developing revolutionary psychedelic treatments, including its novel molecule MEAI, for addiction. Their work aims to provide breakthrough solutions.

Correlation is a European network that strengthens harm reduction organizations, fosters community-based research, and advocates for human-rights-based drug policies.

The Czech Psychedelic Society provides information on the benefits and risks of psychedelics. They work to destigmatize these substances, facilitate their integration into therapeutic settings, and mitigate risks.

Drugreporter is the drug policy website of the Rights Reporter Foundation, promoting drug policy reform and harm reduction through news, films, and training for activists and professionals in Hungary and Europe.

Drug Science works to provide an evidence base free from political or commercial influence, creating the foundation for sensible and effective drug laws, and educating the public, media and policy makers.

The Emergent Phenomenology Research Consortium (EPRC) bridges clinical, scientific, and spiritual paradigms to improve outcomes in mental healthcare, conducting rigorous, multidisciplinary research.

The Fireside Project minimizes psychedelic experience risks through a support line, coaching program, and practitioner training, prioritizing compassion, accountability, and transparency.

The Global Psychedelic Society (GPS) is a worldwide organization supporting local psychedelic communities to advocate for responsible psychedelic use, promote research and safe access, and shift cultural dialogue.

The Heroic Hearts Project is dedicated to helping veterans with PTSD access psychedelic programs, aiming to prevent veteran suicide and suffering by facilitating access to healing and supporting research.

The International Center for Ethnobotanical Education, Research, and Service is a non-profit organization addressing the social, legal, cultural, and health-related dimensions of traditional medicines such as ayahuasca and iboga.

Inawe Foundation is a non-profit organization dedicated to advancing innovation in mental health through the development of an ecosystem that supports the implementation of Psychedelic-Assisted Therapies (PAT).

Integration Communications offers industry-leading PR, media relations, and crisis management services for the psychedelic science, therapy, health, and wellness sectors, helping organizations expand with integrity.

Jellinek is a highly experienced Dutch organization specializing in prevention and treatment for substance use and addiction. They offer support to individuals, families, and professionals, advocating for less stigma.

The Microdosing Institute is a global platform based in the Netherlands that provides education, community, and research on microdosing psychedelics. They connect ancestral wisdom with modern science.

The MIND Foundation is a non-profit organization dedicated to bringing psychedelic therapies into public healthcare through research, education, and training for psychedelic-assisted psychotherapy.

Nachtschatten Verlag is a Swiss publisher specializing in books about drugs, addiction, and consciousness-altering plants, known for its independent, scientifically based information.

Norsk Psykedelisk Vitenskap (Norwegian Psychedelic Science) is a Norwegian association for professionals and academics interested in psychedelic science, focusing on knowledge transfer and networking.

The Psychedelic Access and Research European Alliance is a non-profit, multistakeholder partnership dedicated to the ethically responsible integration of psychedelic therapies into European health services.

PRISM (Psychedelic Research in Science & Medicine) is a charity supporting research and technology development for medicinal psychedelics to improve wellbeing and treat conditions with limited current therapies.

PsyCare NL provides mental health services and a safe space for individuals experiencing challenging experiences at festivals in the Netherlands. They offer psychological care tailored to these unique situations.

UK Welfare & Harm Reduction is a charity that provides welfare and harm reduction services at music festivals and events throughout the UK and internationally. It is known for specialist and compassionate services.

Germany’s non-profit platform for education, research, and cultural dialogue that responsibly reintroduces the transformative potential of psychedelic experiences into society.

Psychedelic Alpha is a leading independent, data-driven platform providing insights into the development, regulation, and commercialization of psychedelic medicines, as well as policy and research.

The Psychedelic Parenthood Community addresses the often-neglected needs and contributions of mothers, fathers, and caregivers within the growing psychedelic movement.

The Psychedelic Women Network unites women across Europe to advance psychedelic science, innovation, and mental health. Their vision is to build a global network rooted in inclusion, respect, and harmony.

PsychedeliCare is a pan-European movement uniting citizens across diverse backgrounds to integrate psychedelic care into European society, grounded in human rights and scientific evidence.

Psychedelics Design opens, informs, and connects the psychedelic field and creative industries. The first global platform of its kind, it brings together events, education, and cultural programming — including an annual design awards and festival — at the intersection of imagination, ethics, and consciousness-expanding practice.

The Finnish Association for Psychedelic Research is a multidisciplinary association with the goals of promoting scientific research related to psychedelics and the availability of accessible information.

SIMEPSI is the first scientific society in Italy dedicated to the research and development of Psychedelic Medicine. It is a multidisciplinary community composed of doctors, therapists, researchers, and humanists.

The Spanish Society of Psychedelic Medicine (SEMPSi) is a non-profit organization comprised of clinical professionals and researchers in the field of mental health. Its objective is to promote the therapeutic use of and research into psychedelic substances within an ethical, culturally respectful, and evidence-based framework. It also carries out scientific outreach and training activities.

The French Psychedelic Society is an association for scientific and cultural mediation on the topic of psychedelic substances. It is also a hub for students and researchers interested in interdisciplinary collaboration.

Studio Aegle serves as a platform for discovering psychedelics, providing educational content and current news, bridging the gap between complex research and public understanding.

The Survivorship Collective offers non-clinical education and support for those facing serious illness, prioritizing dignity, community, autonomy, and ethical stewardship of medicine through survivor-led design and long-term care.

Synergetic Press is an independent publisher, promoting transformative ideas in ecology, consciousness, psychedelics, and social justice to inspire change and a reciprocal relationship with the planet.

PsyRes supports innovative treatments for mental illnesses, particularly psychedelic-assisted psychotherapy, in the Czech Republic.

The Psychedelic Society fosters connection and transforms understanding of psychedelics through practices, events, and education, operating as a worker co-operative.

Women On Psychedelics (WOOP) is a community movement empowering women through education, harm reduction, and authenticity, offering online and in-person events, retreats, and ceremonies.